Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3845-3848

  Tomita, Masaki ^a   Matsuzaki, Yasunori ^a   Shimizu, Tetsuya ^a   Hara, Masaki ^a   Ayabe, Takanori ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Non small cell lung cancer; Serum CEA; T status

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 33750744074     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ford CHJ, Stokes HJ and Newman CE: Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels. Br J Cancer 44: 145-153, 1981.
2. Vincent RG, Chu TM, Fergen TB and Ostrander M: Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer 36: 2069-2076, 1975.
3. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P and Levasseur P: Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 58: 811-814, 1994.
4. Rubins JB, Dunitz J, Rubins HB, Maddaus MA and Niewoehner DE: Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 116: 412-416, 1998.
5. Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M and Onitsuka T: Prognostic significance of preoperative serum carcinoembrryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg 10: 76-80, 2004.
6. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A and Tsubota N: Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78: 216-221, 2004.
7. Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K and Eguchi K: Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Anticancer Res 20: 2177-2180, 2000.
8. Takamochi K, Nagai K, Suzuki K, Yoshida J, Ohde Y and Nishiwaki Y: Clinical predictors of N2 disease in non-small cell lung cancer. Chest 117: 1577-1582, 2000.
9. Diez M, Torres A, Maestro ML, Ortega MD, Gomez A, Pollan M, Lopez JA, Picardo A, Hernando F and Balibrea JL: Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer 73: 1248-1254, 1996.
10. Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S and O'Lear S: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res 54: 2908-2913, 1994.
11. Patz EF, Jr., Rossi S, Harpole DH Jr, Herndon JE and Goodman PC: Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest 117: 1568-1571, 2000.
12. Gajra A, Newman N, Gamble GP, Abraham NZ, Kohman LJ and Graziano SL: Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 42: 51-57, 2003.
13. Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M and Altorki NK: Tumor size predicts survival within stage IA non-small cell lung cancer. Chest 124: 1828-1833, 2003.